Decellularized Intervertebral Disc Scaffold for Nucleus Pulposus Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies for intervertebral disc degeneration and herniation are palliative and do not address the regeneration or replacement of healthy nucleus pulposus tissue, with existing biomaterial scaffolds facing challenges in mimicking native microarchitecture, biochemistry, and mechanical properties, and in effectively supporting seeded cells.
Innovation Solution
A decellularized bovine intervertebral disc tissue is developed, treated with a decellularization solution containing non-ionic surfactants and protease inhibitors, followed by ultrasonication and enzyme treatment to remove cellular content, resulting in a biomaterial that retains glycosaminoglycans and collagen, mimicking native tissue properties and supporting cell viability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If decellularization methods are used to remove host cells from source tissue, then immunogenic materials are reduced, but desirable ECM components such as GAG are significantly reduced
Solution Approach 1:
The patent applies different treatments to different components within the tissue: mild decellularization conditions preserve GAG-rich areas while removing cells, and selective enzymatic digestion removes DNA from collagen-rich areas while preserving GAGs. This localized differential treatment resolves the contradiction between removing immunogenic materials and preserving desirable ECM components.
Solution Approach 2:
The patent changes the parameters of decellularization treatment over time and space - using mild initial conditions to preserve GAGs, then applying selective enzymatic digestion later to remove DNA. This temporal and parametric progression allows separation of the two goals: first preserving GAG content, then removing immunogenic DNA without further GAG loss.
2Object-affected harmful factors
If aggressive decellularization methods are used to completely remove cell DNA, then immunogenicity is reduced, but the native ECM structure is disrupted
Solution Approach 1:
The patent performs preliminary mild decellularization to remove most cells while preserving ECM structure, then applies selective enzymatic digestion only to remaining DNA in collagen-rich areas. This staged approach prevents structural disruption that would occur with single-step aggressive treatment.
Solution Approach 2:
The patent uses selective enzymes as intermediaries that specifically target DNA in collagen-rich areas without affecting GAGs or overall ECM structure. These enzymes mediate between the need to remove DNA and the need to preserve native ECM architecture.
3Ease of operation
If pre-formed hydrogel scaffolds are used to support stem cells, then cell delivery is improved, but the scaffolds fail to mimic native tissue microarchitecture and biochemistry
Solution Approach 1:
The patent creates a scaffold by copying native tissue architecture through decellularization of actual intervertebral disc tissue. This natural template copying preserves the complex microarchitecture, GAG distribution, and biochemical cues that synthetic hydrogels cannot replicate, while still providing cell delivery capability.
Solution Approach 2:
The patent creates a composite scaffold containing multiple ECM components (collagen, GAGs, proteoglycans) in their native spatial relationships. This composite structure combines the structural support of collagen with the bioactive properties of GAGs, providing both mechanical integrity and biological functionality that homogeneous synthetic hydrogels lack.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The biomaterial effectively supports cell viability and maintains mechanical properties similar to healthy intervertebral disc tissue, providing a promising scaffold for regenerating nucleus pulposus tissue and potentially addressing degeneration and herniation.
Implementation Method 1
treated with a decellularization solution containing non-ionic surfactants and protease inhibitors
Implementation Method 2
treated with a decellularization solution containing non-ionic surfactants and protease inhibitors
Implementation Method 3
followed by ultrasonication and enzyme treatment to remove cellular content
Implementation Method 4
followed by ultrasonication and enzyme treatment to remove cellular content
Data Source
Figure 1
Figure 2
Figure 3A~3D
AI summary
Methods for developing a decellularized tissue and biomaterials for use as biomimetic grafts or in vitro cellular scaffolds formed with the decellularized tissue are described. The biomaterials are particularly well suited for use as an intervertebral disc graft. The decellularized tissue is formed from an intervertebral disc source tissue and can be substantially decellularized and substantially free of potential immunogenic material (e.g., DNA and RNA), while maintaining ECM materials including both glycosaminoglycan and collagen.